BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 7594462)

  • 1. Expression of ecto-adenosine deaminase and CD26 in human T cells triggered by the TCR-CD3 complex. Possible role of adenosine deaminase as costimulatory molecule.
    Martín M; Huguet J; Centelles JJ; Franco R
    J Immunol; 1995 Nov; 155(10):4630-43. PubMed ID: 7594462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytokines regulate membrane adenosine deaminase on human activated lymphocytes.
    Cordero OJ; Salgado FJ; Fernández-Alonso CM; Herrera C; Lluis C; Franco R; Nogueira M
    J Leukoc Biol; 2001 Dec; 70(6):920-30. PubMed ID: 11739555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1F7 (CD26): a marker of thymic maturation involved in the differential regulation of the CD3 and CD2 pathways of human thymocyte activation.
    Dang NH; Torimoto Y; Shimamura K; Tanaka T; Daley JF; Schlossman SF; Morimoto C
    J Immunol; 1991 Nov; 147(9):2825-32. PubMed ID: 1717577
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell surface modulation of CD26 by anti-1F7 monoclonal antibody. Analysis of surface expression and human T cell activation.
    Dang NH; Torimoto Y; Sugita K; Daley JF; Schow P; Prado C; Schlossman SF; Morimoto C
    J Immunol; 1990 Dec; 145(12):3963-71. PubMed ID: 1979581
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determination of adenosine deaminase binding domain on CD26 and its immunoregulatory effect on T cell activation.
    Dong RP; Tachibana K; Hegen M; Munakata Y; Cho D; Schlossman SF; Morimoto C
    J Immunol; 1997 Dec; 159(12):6070-6. PubMed ID: 9550406
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of adenosine deaminase binding to human CD26 on T cells and its biologic role in immune response.
    Dong RP; Kameoka J; Hegen M; Tanaka T; Xu Y; Schlossman SF; Morimoto C
    J Immunol; 1996 Feb; 156(4):1349-55. PubMed ID: 8568233
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation of cord T lymphocytes. IV. Analysis of surface expression and functional role of 1F7 (CD26) molecule.
    Gerli R; Agea E; Muscat C; Ercolani R; Bistoni O; Tognellini R; Mariggió MA; Spinozzi F; Bertotto A
    Cell Immunol; 1994 Apr; 155(1):205-18. PubMed ID: 7909498
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse.
    Pacheco R; Martinez-Navio JM; Lejeune M; Climent N; Oliva H; Gatell JM; Gallart T; Mallol J; Lluis C; Franco R
    Proc Natl Acad Sci U S A; 2005 Jul; 102(27):9583-8. PubMed ID: 15983379
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adenosine A2B receptors behave as an alternative anchoring protein for cell surface adenosine deaminase in lymphocytes and cultured cells.
    Herrera C; Casadó V; Ciruela F; Schofield P; Mallol J; Lluis C; Franco R
    Mol Pharmacol; 2001 Jan; 59(1):127-34. PubMed ID: 11125033
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Binding of adenosine deaminase to the lymphocyte surface via CD26.
    De Meester I; Vanham G; Kestens L; Vanhoof G; Bosmans E; Gigase P; Scharpé S
    Eur J Immunol; 1994 Mar; 24(3):566-70. PubMed ID: 7907293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenosine deaminase binding to human CD26 is inhibited by HIV-1 envelope glycoprotein gp120 and viral particles.
    Valenzuela A; Blanco J; Callebaut C; Jacotot E; Lluis C; Hovanessian AG; Franco R
    J Immunol; 1997 Apr; 158(8):3721-9. PubMed ID: 9103436
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A humanised therapeutic CD4 mAb inhibits TCR-induced IL-2, IL-4, and IL-10 secretion and expression of CD25, CD40L, and CD69.
    Woods M; Guy R; Waldmann H; Glennie M; Alexander DR
    Cell Immunol; 1998 May; 185(2):101-13. PubMed ID: 9636688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulation of adenosine receptor engagement by ecto-adenosine deaminase.
    Hashikawa T; Hooker SW; Maj JG; Knott-Craig CJ; Takedachi M; Murakami S; Thompson LF
    FASEB J; 2004 Jan; 18(1):131-3. PubMed ID: 14630704
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-induced CD3-CD4 coligation inhibits TCR/CD3 activation in the absence of costimulatory signals in normal mouse CD4(+) T lymphocytes.
    Portolés P; de Ojeda G; Criado G; Fernández-Centeno E; Rojo JM
    Cell Immunol; 1999 Aug; 195(2):96-109. PubMed ID: 10448009
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of dipeptidyl peptidase IV on enzymatic properties of adenosine deaminase.
    Sharoyan S; Antonyan A; Mardanyan S; Lupidi G; Cristalli G
    Acta Biochim Pol; 2006; 53(3):539-46. PubMed ID: 16929383
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The adenosine deaminase-binding region is distinct from major anti-CD26 mAb epitopes on the human dipeptidyl peptidase IV(CD26) molecule.
    Hühn J; Olek S; Fleischer B; von Bonin A
    Cell Immunol; 1999 Feb; 192(1):33-40. PubMed ID: 10066344
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD26/dipeptidyl peptidase IV does not work as an adenosine deaminase-binding protein in rat cells.
    Iwaki-Egawa S; Watanabe Y; Fujimoto Y
    Cell Immunol; 1997 Jun; 178(2):180-6. PubMed ID: 9225009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cytoplasmic tail of the T cell receptor zeta chain is required for signaling via CD26.
    Mittrücker HW; Steeg C; Malissen B; Fleischer B
    Eur J Immunol; 1995 Jan; 25(1):295-7. PubMed ID: 7843246
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Simultaneous ligation of CD5 and CD28 on resting T lymphocytes induces T cell activation in the absence of T cell receptor/CD3 occupancy.
    Verwilghen J; Vandenberghe P; Wallays G; de Boer M; Anthony N; Panayi GS; Ceuppens JL
    J Immunol; 1993 Feb; 150(3):835-46. PubMed ID: 7678624
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.